Trial intelligence / Profile preview

GABA Agonists for Cocaine Abuse

NCT00218166Phase 2Completed

Sponsor
National Institute on Drug Abuse
Start
Aug 2001
Primary completion
May 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tiagabine, baclofen, triazolam in cocaine use disorder (CUD), sponsored by National Institute on Drug Abuse. Started Aug 2001; status: completed.

02

Drugs

tiagabinebaclofentriazolam
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT00218166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00218166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call